Huatai (06886): Huatai International provided guarantee for the $0.40 billion medium-term notes issued by Huatai International Finance.
Huatai Securities (06886) announces that its overseas wholly-owned subsidiary, Huatai International Financial Holdings Limited (below...
Huatai (06886) announced that its overseas wholly-owned subsidiary, Huatai International Financial Holdings Limited (hereinafter referred to as "Huatai International"), has established an offshore medium-term note program with a maximum aggregate principal amount of USD 3 billion (or equivalent in other currencies) on October 27, 2020 (hereinafter referred to as the "MTN Program"). This MTN Program is guaranteed by Huatai International (hereinafter referred to as "this guarantee").
On July 23, 2025, Huatai International Finance issued a medium-term note under the above MTN Program with an issuance amount of USD 0.40 billion. Based on the USD to RMB exchange rate on June 30, 2025 (1 USD = 7.1586 RMB), the total guarantee amount is RMB 2.86 billion.
The issuance of the medium-term note in the amount of USD 0.40 billion is mainly to support business development and supplement daily operating funds. The issuer, Huatai International Finance, is a subsidiary of Huatai International, the overseas wholly-owned subsidiary of the company. Huatai International Finance has a debt-to-equity ratio of over 70%, but with the company holding 100% ownership of Huatai International, it can promptly assess its debt repayment ability, ensuring that the guarantee risk is controllable and will not harm the interests of the company and its shareholders.
Related Articles

HK Bull/Bear Outstanding Qty Ratio(60:40) | July 24th

SENSETIME-W(00020) plans to issue approximately 1.667 billion new Class B shares to Infinity Capital, raising approximately HK$2.498 billion to further consolidate its leading position in the field of generative artificial intelligence.

KINTOR PHARMA-B(09939): KX- 826 1.0% solution achieved the primary endpoint in the Phase II clinical trial for treating androgenetic alopecia in adult males in China.
HK Bull/Bear Outstanding Qty Ratio(60:40) | July 24th

SENSETIME-W(00020) plans to issue approximately 1.667 billion new Class B shares to Infinity Capital, raising approximately HK$2.498 billion to further consolidate its leading position in the field of generative artificial intelligence.

KINTOR PHARMA-B(09939): KX- 826 1.0% solution achieved the primary endpoint in the Phase II clinical trial for treating androgenetic alopecia in adult males in China.

RECOMMEND

Backed by BYD, Why Has the Leading EV Charger Firm Seen Revenue Declines and Surging Losses?
23/07/2025

Just Days Away from Losing Tens of Millions of Dollars! Copper-Laden Ships Race Toward U.S. Ports
23/07/2025

Japan "Surrenders"? Trump Claims "U.S. and Japan Reach Deal: Japan Accepts 15% Tariff Rate, Opens Auto and Rice Markets, Pledges $550 Billion in U.S. Investments"
23/07/2025